{"entity":{"type":"insider","cik":"0001697802","url":"/insider/0001697802","json_url":"/insider/0001697802.json","name":"Yi Kathy","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":15,"first":"2018-03-16","last":"2019-05-17","span_basis":"filed_date"},"name_variants":[{"name":"Yi Kathy","source":"filing","n_filings":15,"first_seen":"2018-03-16","last_seen":"2019-05-17"}],"transactions":[{"id":7882913,"accession":"0001209191-19-031065","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-031065","line_url":"/filing/0001209191-19-031065#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001697802","owner_name":"Yi Kathy","owner_display_name":"Yi Kathy","owner_url":"/insider/0001697802","role":"Officer (EVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":50000.0,"total_display":"50,000.00","total_whole":"50,000","shares_owned_after":25512.0,"shares_owned_after_display":"25,512","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-15","filed_date":"2019-05-17","scope":"insider"},{"id":8099746,"accession":"0001209191-19-024836","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-024836","line_url":"/filing/0001209191-19-024836#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001697802","owner_name":"Yi Kathy","owner_display_name":"Yi Kathy","owner_url":"/insider/0001697802","role":"Officer (EVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":12.11,"price_display":"12.11","price_state":"stated","total_value":60550.0,"total_display":"60,550.00","total_whole":"60,550","shares_owned_after":25512.0,"shares_owned_after_display":"25,512","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-15","filed_date":"2019-04-16","scope":"insider"},{"id":7921960,"accession":"0001209191-19-020126","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-020126","line_url":"/filing/0001209191-19-020126#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001697802","owner_name":"Yi Kathy","owner_display_name":"Yi Kathy","owner_url":"/insider/0001697802","role":"Officer (EVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":50000.0,"total_display":"50,000.00","total_whole":"50,000","shares_owned_after":25512.0,"shares_owned_after_display":"25,512","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-15","filed_date":"2019-03-18","scope":"insider"},{"id":8004474,"accession":"0001209191-19-017164","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-017164","line_url":"/filing/0001209191-19-017164#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001697802","owner_name":"Yi Kathy","owner_display_name":"Yi Kathy","owner_url":"/insider/0001697802","role":"Officer (EVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":50000.0,"total_display":"50,000.00","total_whole":"50,000","shares_owned_after":25512.0,"shares_owned_after_display":"25,512","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-01","filed_date":"2019-03-05","scope":"insider"},{"id":8116833,"accession":"0001209191-19-003926","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-003926","line_url":"/filing/0001209191-19-003926#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001697802","owner_name":"Yi Kathy","owner_display_name":"Yi Kathy","owner_url":"/insider/0001697802","role":"Officer (SVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":11.04,"price_display":"11.04","price_state":"stated","total_value":55200.0,"total_display":"55,200.00","total_whole":"55,200","shares_owned_after":7250.0,"shares_owned_after_display":"7,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-15","filed_date":"2019-01-16","scope":"insider"},{"id":6766202,"accession":"0001209191-18-063265","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-063265","line_url":"/filing/0001209191-18-063265#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001697802","owner_name":"Yi Kathy","owner_display_name":"Yi Kathy","owner_url":"/insider/0001697802","role":"Officer (SVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":11.44,"price_display":"11.44","price_state":"stated","total_value":57200.0,"total_display":"57,200.00","total_whole":"57,200","shares_owned_after":7250.0,"shares_owned_after_display":"7,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-17","filed_date":"2018-12-18","scope":"insider"},{"id":6662888,"accession":"0001209191-18-059015","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-059015","line_url":"/filing/0001209191-18-059015#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001697802","owner_name":"Yi Kathy","owner_display_name":"Yi Kathy","owner_url":"/insider/0001697802","role":"Officer (SVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":50000.0,"total_display":"50,000.00","total_whole":"50,000","shares_owned_after":7250.0,"shares_owned_after_display":"7,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-15","filed_date":"2018-11-16","scope":"insider"},{"id":6727391,"accession":"0001209191-18-055200","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-055200","line_url":"/filing/0001209191-18-055200#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001697802","owner_name":"Yi Kathy","owner_display_name":"Yi Kathy","owner_url":"/insider/0001697802","role":"Officer (SVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":13.97,"price_display":"13.97","price_state":"stated","total_value":69850.0,"total_display":"69,850.00","total_whole":"69,850","shares_owned_after":7250.0,"shares_owned_after_display":"7,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-15","filed_date":"2018-10-16","scope":"insider"},{"id":6021194,"accession":"0001209191-18-051500","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-051500","line_url":"/filing/0001209191-18-051500#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001697802","owner_name":"Yi Kathy","owner_display_name":"Yi Kathy","owner_url":"/insider/0001697802","role":"Officer (SVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":14.6569,"price_display":"14.66","price_state":"stated","total_value":73284.5,"total_display":"73,284.50","total_whole":"73,285","shares_owned_after":7250.0,"shares_owned_after_display":"7,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-17","filed_date":"2018-09-18","scope":"insider"},{"id":6101961,"accession":"0001209191-18-047359","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-047359","line_url":"/filing/0001209191-18-047359#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001697802","owner_name":"Yi Kathy","owner_display_name":"Yi Kathy","owner_url":"/insider/0001697802","role":"Officer (SVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":15.3903,"price_display":"15.39","price_state":"stated","total_value":76951.5,"total_display":"76,951.50","total_whole":"76,952","shares_owned_after":7250.0,"shares_owned_after_display":"7,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-16","filed_date":"2018-08-17","scope":"insider"},{"id":6292268,"accession":"0001209191-18-042845","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-042845","line_url":"/filing/0001209191-18-042845#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001697802","owner_name":"Yi Kathy","owner_display_name":"Yi Kathy","owner_url":"/insider/0001697802","role":"Officer (SVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":14.772,"price_display":"14.77","price_state":"stated","total_value":73860.0,"total_display":"73,860.00","total_whole":"73,860","shares_owned_after":7250.0,"shares_owned_after_display":"7,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-16","filed_date":"2018-07-17","scope":"insider"},{"id":6495461,"accession":"0001209191-18-038208","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-038208","line_url":"/filing/0001209191-18-038208#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001697802","owner_name":"Yi Kathy","owner_display_name":"Yi Kathy","owner_url":"/insider/0001697802","role":"Officer (SVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":15.673,"price_display":"15.67","price_state":"stated","total_value":78365.0,"total_display":"78,365.00","total_whole":"78,365","shares_owned_after":7250.0,"shares_owned_after_display":"7,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-15","filed_date":"2018-06-15","scope":"insider"},{"id":6134082,"accession":"0001209191-18-030691","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-030691","line_url":"/filing/0001209191-18-030691#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001697802","owner_name":"Yi Kathy","owner_display_name":"Yi Kathy","owner_url":"/insider/0001697802","role":"Officer (SVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":15.384,"price_display":"15.38","price_state":"stated","total_value":76920.0,"total_display":"76,920.00","total_whole":"76,920","shares_owned_after":7250.0,"shares_owned_after_display":"7,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-15","filed_date":"2018-05-16","scope":"insider"},{"id":6421304,"accession":"0001209191-18-025351","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-025351","line_url":"/filing/0001209191-18-025351#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001697802","owner_name":"Yi Kathy","owner_display_name":"Yi Kathy","owner_url":"/insider/0001697802","role":"Officer (SVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":19.8288,"price_display":"19.83","price_state":"stated","total_value":99144.0,"total_display":"99,144.00","total_whole":"99,144","shares_owned_after":7250.0,"shares_owned_after_display":"7,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-16","filed_date":"2018-04-18","scope":"insider"},{"id":6604223,"accession":"0001209191-18-020419","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-020419","line_url":"/filing/0001209191-18-020419#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001697802","owner_name":"Yi Kathy","owner_display_name":"Yi Kathy","owner_url":"/insider/0001697802","role":"Officer (SVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":25.5624,"price_display":"25.56","price_state":"stated","total_value":127812.0,"total_display":"127,812.00","total_whole":"127,812","shares_owned_after":7250.0,"shares_owned_after_display":"7,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-15","filed_date":"2018-03-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001001233","name":"SANGAMO THERAPEUTICS, INC","url":"/issuer/0001001233","role":"Officer (EVP & Chief Financial Officer)","n_filings":15,"first_seen":"2018-03-16","last_seen":"2019-05-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001697802","retrieved_at":"2026-08-25T14:19:24+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}